These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 28817374)
1. Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis. Nelson DB; Rice DC; Niu J; Atay S; Vaporciyan AA; Antonoff M; Hofstetter WL; Walsh GL; Swisher SG; Roth JA; Tsao A; Gomez D; Giordano SH; Mehran R; Sepesi B J Clin Oncol; 2017 Oct; 35(29):3354-3362. PubMed ID: 28817374 [TBL] [Abstract][Full Text] [Related]
2. Trimodality Treatment of Malignant Pleural Mesothelioma: An Institutional Review. Kapeles M; Gensheimer MF; Mart DA; Sottero TL; Kusano AS; Truong A; Farjah F; Laramore GE; Stelzer KJ; Patel SA Am J Clin Oncol; 2018 Jan; 41(1):30-35. PubMed ID: 26353120 [TBL] [Abstract][Full Text] [Related]
3. Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma? Kim S; Bull DA; Garland L; Khalpey Z; Stea B; Yi S; Hsu CC Ann Thorac Surg; 2019 Jan; 107(1):194-201. PubMed ID: 30278171 [TBL] [Abstract][Full Text] [Related]
5. Disparities in Compliance With National Guidelines for the Treatment of Malignant Pleural Mesothelioma. Espinoza-Mercado F; Borgella JD; Berz D; Alban RF; Sarkissian A; Imai HTA; Soukiasian HJ Ann Thorac Surg; 2019 Sep; 108(3):889-896. PubMed ID: 31004585 [TBL] [Abstract][Full Text] [Related]
6. Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma. Shaikh F; Zauderer MG; von Reibnitz D; Wu AJ; Yorke ED; Foster A; Shi W; Zhang Z; Adusumilli PS; Rosenzweig KE; Krug LM; Rusch VW; Rimner A J Thorac Oncol; 2017 Jun; 12(6):993-1000. PubMed ID: 28341225 [TBL] [Abstract][Full Text] [Related]
7. Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients. Taioli E; Wolf AS; Camacho-Rivera M; Kaufman A; Lee DS; Nicastri D; Rosenzweig K; Flores RM PLoS One; 2015; 10(12):e0145039. PubMed ID: 26660351 [TBL] [Abstract][Full Text] [Related]
8. An Investigation of Cancer-Directed Surgery for Different Histologic Subtypes of Malignant Pleural Mesothelioma. Mansur A; Potter AL; Zurovec AJ; Nathamuni KV; Meyerhoff RR; Berry MF; Kang A; Jeffrey Yang CF Chest; 2023 May; 163(5):1292-1303. PubMed ID: 36574925 [TBL] [Abstract][Full Text] [Related]
9. Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival. Verma V; Ahern CA; Berlind CG; Lindsay WD; Shabason J; Sharma S; Culligan MJ; Grover S; Friedberg JS; Simone CB Clin Lung Cancer; 2018 Nov; 19(6):e901-e912. PubMed ID: 30224273 [TBL] [Abstract][Full Text] [Related]
10. Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy. Batirel HF; Metintas M; Caglar HB; Ak G; Yumuk PF; Yildizeli B; Yuksel M J Thorac Cardiovasc Surg; 2016 Feb; 151(2):478-84. PubMed ID: 26611742 [TBL] [Abstract][Full Text] [Related]